Skip to main content
. 2015 Dec 23;12:225. doi: 10.1186/s12985-015-0453-7

Fig. 2.

Fig. 2

ALT levels of individual patients from pretreatment to end of treatment, and at 0.5, 1, 2, 3, 4 and 5 years after completion of treatment according to the duration of PEG-IFN treatment a with ALT levels rebound, b without ALT levels rebound. EOT: End of treatment